Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Autoimmune Disorders

  Free Subscription


26.02.2018

1 BMC Neurol
1 Brain
14 Diabet Med
2 Intern Med
5 J Autoimmun
1 J Neuroimmunol
2 J Neurol
2 J Rheumatol
1 Kidney Int
2 Mult Scler
1 PLoS One
2 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. MORLEY D, Dummett S, Kelly L, Fitzpatrick R, et al
    Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson's disease.
    BMC Neurol. 2018;18:19.
    PubMed     Text format     Abstract available


    Brain

  2. ARRAMBIDE G, Tintore M, Espejo C, Auger C, et al
    The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
    Brain. 2018 Feb 16. pii: 4866204. doi: 10.1093.
    PubMed     Text format     Abstract available


    Diabet Med

  3. GEE BT, Nansel TR, Liu A
    Reduction of hypoglycaemic events with a behavioural intervention: a randomized clinical trial for paediatric patients with Type 1 diabetes mellitus.
    Diabet Med. 2017;34:340-347.
    PubMed     Text format     Abstract available

  4. MCGOVERN AP, Fieldhouse H, Tippu Z, Jones S, et al
    Glucose test provenance recording in UK primary care: was that fasted or random?
    Diabet Med. 2017;34:93-98.
    PubMed     Text format     Abstract available

  5. YESILKAYA E, Cinaz P, Andiran N, Bideci A, et al
    First report on the nationwide incidence and prevalence of Type 1 diabetes among children in Turkey.
    Diabet Med. 2017;34:405-410.
    PubMed     Text format     Abstract available

  6. GAGNUM V, Stene LC, Jenssen TG, Berteussen LM, et al
    Causes of death in childhood-onset Type 1 diabetes: long-term follow-up.
    Diabet Med. 2017;34:56-63.
    PubMed     Text format     Abstract available

  7. HORIGAN G, Davies M, Findlay-White F, Chaney D, et al
    Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review.
    Diabet Med. 2017;34:14-26.
    PubMed     Text format     Abstract available

  8. SANDAHL K, Nielsen LB, Svensson J, Johannesen J, et al
    Increased mortality in a Danish cohort of young people with Type 1 diabetes mellitus followed for 24 years.
    Diabet Med. 2017;34:380-386.
    PubMed     Text format     Abstract available

  9. HAKKARAINEN P, Moilanen L, Hanninen V, Rasanen K, et al
    Disclosure of Type 1 diabetes at work among Finnish workers.
    Diabet Med. 2017;34:115-119.
    PubMed     Text format     Abstract available

  10. STEWART CJ, Nelson A, Campbell MD, Walker M, et al
    Gut microbiota of Type 1 diabetes patients with good glycaemic control and high physical fitness is similar to people without diabetes: an observational study.
    Diabet Med. 2017;34:127-134.
    PubMed     Text format     Abstract available

  11. HAMMER E, Lilienthal E, Hofer SE, Schulz S, et al
    Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus.
    Diabet Med. 2017;34:86-92.
    PubMed     Text format     Abstract available

  12. ARIF S, Gibson VB, Nguyen V, Bingley PJ, et al
    beta-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with Type 1 diabetes compared with adults.
    Diabet Med. 2016 May 6. doi: 10.1111/dme.13153.
    PubMed     Text format     Abstract available

  13. EBERT DD, Nobis S, Lehr D, Baumeister H, et al
    The 6-month effectiveness of Internet-based guided self-help for depression in adults with Type 1 and 2 diabetes mellitus.
    Diabet Med. 2016 Jun 23. doi: 10.1111/dme.13173.
    PubMed     Text format     Abstract available

  14. UCHENDU C, Blake H
    Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
    Diabet Med. 2016 Jul 29. doi: 10.1111/dme.13195.
    PubMed     Text format     Abstract available

  15. HANSEN CS, Fleischer J, Vistisen D, Ridderstrale M, et al
    High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes.
    Diabet Med. 2016 Oct 1. doi: 10.1111/dme.13269.
    PubMed     Text format     Abstract available

  16. ADAMSSON ERYD S, Svensson AM, Franzen S, Eliasson B, et al
    Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
    Diabet Med. 2016 Sep 20. doi: 10.1111/dme.13266.
    PubMed     Text format     Abstract available


    Intern Med

  17. OHARA N, Koda R, Watanabe H, Iino N, et al
    Generalized Status Epilepticus in a Patient with Acute-onset Type 1 Diabetes Mellitus Associated with Severe Kidney Dysfunction: A Case Report and Literature Review.
    Intern Med. 2017;56:1993-1999.
    PubMed     Text format     Abstract available

  18. TOHGE R, Shinoto Y, Takahashi M
    Longitudinally Extensive Transverse Myelitis and Optic Neuropathy Associated with Syphilitic Meningomyelitis and Human Immunodeficiency Virus Infection: A Case Report and Review of the Literature.
    Intern Med. 2017;56:2067-2072.
    PubMed     Text format     Abstract available


    J Autoimmun

  19. LOMBARDI A, Tomer Y
    Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.
    J Autoimmun. 2017;80:48-55.
    PubMed     Text format     Abstract available

  20. SHIBATA A, Sugiura K, Furuta Y, Mukumoto Y, et al
    Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.
    J Autoimmun. 2017;80:28-38.
    PubMed     Text format     Abstract available

  21. GILLIS CM, Zenatti PP, Mancardi DA, Beutier H, et al
    In vivo effector functions of high-affinity mouse IgG receptor FcgammaRI in disease and therapy models.
    J Autoimmun. 2017;80:95-102.
    PubMed     Text format     Abstract available

  22. CHIGHIZOLA CB, Pregnolato F, Andreoli L, Bodio C, et al
    Beyond thrombosis: Anti-beta2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.
    J Autoimmun. 2018 Feb 14. pii: S0896-8411(17)30698.
    PubMed     Text format     Abstract available

  23. CHIGHIZOLA CB, Andreoli L, Gerosa M, Tincani A, et al
    The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.
    J Autoimmun. 2018 Feb 12. pii: S0896-8411(18)30054.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  24. IP PP, Chung CY, Chang CC, Lee YF, et al
    Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
    J Neuroimmunol. 2018 Feb 8. pii: S0165-5728(17)30498.
    PubMed     Text format     Abstract available


    J Neurol

  25. VAN DER VUURST DE VRIES RM, Mescheriakova JY, Runia TF, Siepman TAM, et al
    Smoking at time of CIS increases the risk of clinically definite multiple sclerosis.
    J Neurol. 2018 Feb 20. pii: 10.1007/s00415-018-8780.
    PubMed     Text format     Abstract available

  26. BROICHER SD, Filli L, Geisseler O, Germann N, et al
    Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years.
    J Neurol. 2018 Feb 20. pii: 10.1007/s00415-018-8796.
    PubMed     Text format     Abstract available


    J Rheumatol

  27. YUE C, Li G, Wen Y, Li X, et al
    Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170561. doi: 10.3899/jrheum.170561.
    PubMed     Text format     Abstract available

  28. CAI F, Han F, Wang H, Han H, et al
    The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170553. doi: 10.3899/jrheum.170553.
    PubMed     Text format     Abstract available


    Kidney Int

  29. BAJEMA IM, Wilhelmus S, Alpers CE, Bruijn JA, et al
    Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.
    Kidney Int. 2018 Feb 16. pii: S0085-2538(17)30859.
    PubMed     Text format     Abstract available


    Mult Scler

  30. JAEGER S, Paul F, Scheel M, Brandt A, et al
    Multiple sclerosis-related fatigue: Altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.
    Mult Scler. 2018 Feb 1:1352458518758911. doi: 10.1177/1352458518758911.
    PubMed     Text format     Abstract available

  31. DE STEFANO N, Giorgio A, Tintore M, Pia Amato M, et al
    Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.
    Mult Scler. 2018;24:214-221.
    PubMed     Text format    


    PLoS One

  32. DAHDAL S, Devetzis V, Chalikias G, Tziakas D, et al
    Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
    PLoS One. 2018;13:e0188695.
    PubMed     Text format     Abstract available


    Thyroid

  33. SUNDARESH V, Brito JP, Thapa P, Bahn RS, et al
    Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism - A Historical Cohort Study.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0343.
    PubMed     Text format     Abstract available

  34. KIM YA, Cho SW, Choi HS, Moon S, et al
    The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
    Thyroid. 2017;27:491-496.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: